• 321880
Product name | B-Tg(mCldn2) MC38 |
---|---|
Catalog number | 321880 |
Strain background | C57BL/6 |
Aliases | AL022813 |
Tissue | Colon |
Disease | Colon carcinoma |
Species | Mouse |
Application | B-Tg(mCldn2) MC38 cells have the capability to establish tumors in vivo |
on this page
The exogenous promoter and mouse Cldn2 coding sequence were inserted into the mouse genome randomly. Mouse Cldn2 is highly expressed on the surface of B-Tg(mCldn2) MC38 cells.
Gene targeting strategy for B-Tg(mCldn2) MC38 cells. The exogenous promoter and mouse Cldn2 coding sequence were inserted into the mouse genome randomly.
Subcutaneous homograft tumor growth of B-Tg(mCldn2) MC38 cells. B-Tg(mCldn2) MC38 cells (5x105) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6 mice (female, 14-week-old, n=6). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean ± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-Tg(mCldn2) MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.
B-Tg(mCldn2) MC38 tumor cells growth of individual mice. B-Tg(mCldn2) MC38 cells (5x105) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6 mice (female, 14-week-old, n=6). As shown in panel, B-Tg(mCldn2) MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.